Showing 611-620 of 974 results for "".
Ophthalmic Presentations of Pituitary Adenoma
https://modernod.com/mod-issues/2020-nov-dec/ophthalmic-presentations-of-pituitary-adenoma/39115/The ocular examination can aid diagnosis and help guide treatment.The Challenges of Benzalkonium Chloride in Glaucoma Care
https://modernod.com/topics/glaucoma/the-challenges-of-benzalkonium-chloride-in-glaucoma-care/54304/A look at the cytotoxic effects on the ocular surface, and the potential of preservative-free medications.What’s New and What’s Coming in OSD Treatment
https://modernod.com/topics/ocular-surface/whats-new-and-whats-coming-in-osd-treatment/38578/An overview of recent FDA approvals and potential new therapies.Nutritional Supplements for Glaucoma
https://modernod.com/topics/glaucoma/nutritional-supplements-for-glaucoma/38342/Dietary recommendations for when your patients ask, “What else can I do?”The Emergence of Longevity Biotechnology in Eye Care
https://modernod.com/topics/technology/the-emergence-of-longevity-biotechnology-in-eye-care/38292/Several strategies are being explored to halt or reverse the effects of aging.The Usual (Retina) Suspects
https://modernod.com/topics/retina/the-usual-retina-suspects/38164/Be on the lookout for these common culprits.MGD Consensus Panel: Taking Aim at Meibomian Gland Dysfunction
https://modernod.com/topics/ocular-surface/mgd-consensus-panel-taking-aim-at-meibomian-gland-dysfunction/38063/Experts examined the impact of MGD and the standard of care for diagnosis and treatment.Retina in Review
https://modernod.com/topics/retina/retina-in-review/38713/An overview of the latest developments and findings related to the treatment and management of diseases of the posterior segment.Inside the Innovator’s Mind
https://modernod.com/mod-issues/2022-mar/inside-the-innovators-mind/38391/What does it take to be a game-changer in optometry? Hear from four innovators who’ve run the gamut.- Aerie Pharmaceuticals Appoints Gary Sternberg, MD, MBA, as Chief Medical Officerhttps://modernod.com/news/aerie-pharmaceuticals-appoints-gary-sternberg-md-mba-as-chief-medical-officer/2480665/Aerie Pharmaceuticals announced that Gary Sternberg, MD, MBA, will join the company as Chief Medical Officer (CMO), effective March 1, 2022. He will report to Raj Kannan, Chief Executive Officer of Aerie Pharmaceuticals and become a member of the Aerie Executive Comm